Literature DB >> 14505905

Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage.

G S Goldman1.   

Abstract

Active surveillance for herpes zoster (HZ) was conducted for 2 years (2000-2001) in the Antelope Valley community of 312,000 residents among 290 public and private schools, daycares, and healthcare providers. The true ascertainment-adjusted HZ incidence rate is 307 per 100,000 person-years and 138 per 100,000 person-years among children <10 and individuals aged 10-19, respectively. The unadjusted rate among vaccinated children is 9.5 per 100,000 person-years and an estimated 22 per 100,000 vaccine doses. Unvaccinated children with a previous history of varicella may have greater sensitivity to exogenous exposures (boosting) and a poorer cell-mediated response following primary infection relative to older age groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505905     DOI: 10.1016/s0264-410x(03)00459-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  A Multi-Vector, Multi-Envelope HIV-1 Vaccine.

Authors:  Julia L Hurwitz; Xiaoyan Zhan; Scott A Brown; Mattia Bonsignori; John Stambas; Timothy D Lockey; Bart Jones; Sherri Surman; Robert Sealy; Pam Freiden; Kristen Branum; Karen S Slobod
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

Review 2.  HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen.

Authors:  Sherri L Surman; Robert Sealy; Bart G Jones; Julia L Hurwitz
Journal:  Hum Vaccin       Date:  2009-04

Review 3.  Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine.

Authors:  Robert Sealy; Karen S Slobod; Patricia Flynn; Kristen Branum; Sherri Surman; Bart Jones; Pamela Freiden; Timothy Lockey; Nanna Howlett; Julia L Hurwitz
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

Review 4.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

Review 5.  Dissecting the indirect effects caused by vaccines into the basic elements.

Authors:  Carla D Scarbrough Lefebvre; Augustin Terlinden; Baudouin Standaert
Journal:  Hum Vaccin Immunother       Date:  2015-07-17       Impact factor: 3.452

6.  Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.

Authors:  Katsiaryna Holl; Christophe Sauboin; Emanuele Amodio; Paolo Bonanni; Giovanni Gabutti
Journal:  BMC Public Health       Date:  2016-10-21       Impact factor: 3.295

7.  Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Hum Exp Toxicol       Date:  2013-11-25       Impact factor: 2.903

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.